Home Top Stories
Moderna Stock Climbs to Two-Month High on Hantavirus Vaccine Development News
Moderna shares jumped 18.6% to US$57.55 on renewed interest in its hantavirus vaccine development.
Blog
Home Top Stories
ASX Shares Amid Rising Interest Rates: Two Stocks To Consider
Rising interest rates are reshaping investor sentiment across global markets, including Australia. …
Home Top Stories
Two Monthly ASX Dividend Stocks Worth Considering for Retirement Income
HYLD and PL8 offer monthly ASX dividend income for retirement-focused investors.
Home Top Stories
3 Super ASX Tech Stocks To Buy In May With $3,000
The recent sell-off across the ASX tech sector has created renewed interest for long-term investors…
Home Top Stories
IREN Rockets 26% After Hours on NVIDIA Partnership and European Acquisition
IREN Limited surges 26% after hours on 8 May 2026 following a landmark NVIDIA AI infrastructure par…
Homepage
What Do TPG Telecom’s 2026 AGM Changes Mean for Investors?
TPG Telecom Limited (ASX: TPG) held its 2026 Annual General Meeting today in a hybrid format. The m…
Home Top Stories
Why Wesfarmers Could Become An AI Winner On The ASX 200
Wesfarmers may not appear like a traditional AI stock, but its scale, customer reach, and OpenAI pa…
Home Top Stories
Gates MegaSys MXT Hydraulic Hose Improves Mining Efficiency
Gates MegaSys MXT hydraulic hose delivers lighter assemblies, easier routing, and stronger durabili…
Home Top Stories
Macquarie Shares Fall Despite 30% Jump in FY26 Profit
Macquarie Group posts a net profit of A$4.85 billion for FY26, up 30%, with a record second-half re…
Home Top Stories
Rox Resources Completes Main Pit Dewatering at Youanmi Gold Mine
Rox Resources completes Main Pit dewatering at Youanmi on 7 May 2026, with underground dewatering n…
Home Top Stories
Ramsay Santé Results Show Strong Revenue And EBITDA Growth
Ramsay Santé reported solid nine-month growth to March 2026. Revenue reached €4.0 billion, while EB…